Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development.

MLA

Uaesoontrachoon, Kitipong, et al. “Orthogonal Analysis of Dystrophin Protein and MRNA as a Surrogate Outcome for Drug Development.” Biomarkers in Medicine, vol. 13, no. 14, Oct. 2019, pp. 1209–25. EBSCOhost, https://doi.org/10.2217/bmm-2019-0242.

APA

Uaesoontrachoon, K., Srinivassane, S., Warford, J., Mekhssian, K., Montpetit, H., Beauvois, R., Keyhani, A., Hathout, Y., Yamashita, T., Satou, Y., Osaki, H., Praest, M., Moraca, M., Malbasic, M., Ross, W., MacKinnon, A., Rowsell, J., Mullen, A., Matyas, M., … Hoffman, E. P. (2019). Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development. Biomarkers in Medicine, 13(14), 1209–1225. https://doi.org/10.2217/bmm-2019-0242

Chicago

Uaesoontrachoon, Kitipong, Sadish Srinivassane, Jordan Warford, Kevork Mekhssian, Hélène Montpetit, Romain Beauvois, Anahita Keyhani, et al. 2019. “Orthogonal Analysis of Dystrophin Protein and MRNA as a Surrogate Outcome for Drug Development.” Biomarkers in Medicine 13 (14): 1209–25. doi:10.2217/bmm-2019-0242.